Clinical Trials Directory

Trials / Unknown

UnknownNCT02439099

Retinoic Acid Homeostasis in Neuropsychiatric Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

It is hypothesized, that local retinoic acid (RA) homeostasis is functionally involved in the pathophysiology of depression. In a cross-sectional (and partly longitudinal) analysis, serum RA status will be assessed in healthy controls and subjects with Major Depression, Alzheimer's disease, alcoholism and in subjects with schizophrenia.

Detailed description

Retinoids comprise of a group of small-molecule derivatives of Vitamin A with retinoic acid (RA) representing the biologically most active endogenous form. RA has multiple functions central nervous system (CNS). It is hypothesized, that local RA homeostasis is functionally involved in the pathophysiology of numerous neuropsychiatric diseases.

Conditions

Timeline

Start date
2015-03-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2015-05-08
Last updated
2021-08-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02439099. Inclusion in this directory is not an endorsement.

Retinoic Acid Homeostasis in Neuropsychiatric Diseases (NCT02439099) · Clinical Trials Directory